Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals
Authors
Keywords
-
Journal
BIOSCIENCE REPORTS
Volume 39, Issue 6, Pages BSR20190610
Publisher
Portland Press Ltd.
Online
2019-05-31
DOI
10.1042/bsr20190610
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Curcumin prevents strokes in stroke-prone spontaneously hypertensive rats by improving vascular endothelial function
- (2018) Cong Lan et al. BMC Cardiovascular Disorders
- LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ductal adenocarcinoma
- (2018) Libin Wang et al. Cancer Biomarkers
- Long Noncoding RNA Discovery in Cardiovascular Disease
- (2018) Tamer Sallam et al. CIRCULATION RESEARCH
- Current status and strategies of long noncoding RNA research for diabetic cardiomyopathy
- (2018) Tarun Pant et al. BMC Cardiovascular Disorders
- From Friend to Enemy: Dissecting the Functional Alteration of Immunoregulatory Components during Pancreatic Tumorigenesis
- (2018) Hui-Ching Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrative Analysis of CD133 mRNA in Human Cancers Based on Data Mining
- (2018) Gui-Min Wen et al. Stem Cell Reviews and Reports
- The Orexin-A-Regulated Akt/mTOR Pathway Promotes Cell Proliferation Through Inhibiting Apoptosis in Pancreatic Cancer Cells
- (2018) Linna Suo et al. Frontiers in Endocrinology
- MicroRNA-373 promotes tumorigenesis of renal cell carcinoma in vitro and in vivo
- (2017) Yanli Li et al. Molecular Medicine Reports
- Long non-coding RNA AB209630 suppresses cell proliferation and metastasis in human hepatocellular carcinoma
- (2017) Teng Li et al. Experimental and Therapeutic Medicine
- Gemcitabine associated pseudocellulitis: A missed diagnosis
- (2017) Dalvir Gill et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Gemcitabine-based chemotherapy in sarcomas: A systematic review of published trials
- (2016) Agnès Ducoulombier et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells
- (2016) Song Gao et al. Evidence-based Complementary and Alternative Medicine
- A rash diagnosis: Gemcitabine-associated pseudocellulitis
- (2016) Christopher Strouse et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Qingyihuaji Formula Inhibits Pancreatic Cancer and Prolongs Survival by Downregulating Hes-1 and Hey-1
- (2015) Yanli Xu et al. Evidence-based Complementary and Alternative Medicine
- Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?
- (2015) Axel Schulenburg et al. Journal of Hematology & Oncology
- Cancer stem cells, cancer cell plasticity and radiation therapy
- (2015) Erina Vlashi et al. SEMINARS IN CANCER BIOLOGY
- EphB2 regulates contact-dependent and contact-independent signaling to control platelet function
- (2014) S. Vaiyapuri et al. BLOOD
- High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway
- (2014) YONG-QIANG HUA et al. Oncology Letters
- Targeting Cancer-Related Inflammation: Chinese Herbal Medicine Inhibits Epithelial-to-Mesenchymal Transition in Pancreatic Cancer
- (2013) Juan Zhang et al. PLoS One
- MicroRNAs and Metastasis-related Gene Expression in Egyptian Breast Cancer Patients
- (2012) Mohamed M. Hafez et al. Asian Pacific Journal of Cancer Prevention
- Cancer Stem Cells as a Predictive Factor in Radiotherapy
- (2012) Thomas B. Brunner et al. SEMINARS IN RADIATION ONCOLOGY
- Qingyihuaji Formula Inhibits Progress of Liver Metastases From Advanced Pancreatic Cancer Xenograft by Targeting to Decrease Expression of Cyr61 and VEGF
- (2011) Jian-Hua Yin et al. INTEGRATIVE CANCER THERAPIES
- Ski Acts as Therapeutic Target of Qingyihuaji Formula in the Treatment of SW1990 Pancreatic Cancer
- (2010) Peng Wang et al. INTEGRATIVE CANCER THERAPIES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now